Nancy Bolsens

Association between worsening time in range and microvascular complications in type 1 diabetes: real-world 5-year study

Amber Sabbe, Niels Bochanen, Annelies Van den Broucke, Katarina Mihaljčić et autres

CONTEXT: Beyond HbA1c, continuous glucose monitoring (CGM) is now widely used in clinical practice, providing more detailed information about glycemic control. However, its ability to predict long-term microvascular outcomes in type 1 diabetes remains unclear. OBJECTIVE: To evaluate the association between CGM-derived …

be (code pays fourni par la source)

Association between worsening time in range and microvascular complications in type 1 diabetes: real-world 5-year study

Amber Sabbe, Niels Bochanen, Annelies Van den Broucke, Katarina Mihaljčić et autres

be (code pays fourni par la source)

The efficacy and safety of switching from rapid acting insulins to ultra rapid insulin l ispro (URLi) in people with type 1 diabetes using continuous glucose monitoring: a real world study

Laura Naert, Peter Coremans, Sabien Driessens, den van et autres

Evaluation of Glucose Metrics in Adults with Type 1 Diabetes Switching to Insulin Glargine 300 U/mL: A Retrospective, Propensity-Score Matched Study

Sara Charleer, Steffen Fieuws, Christophe E.M. De Block, Nancy Bolsens et autres

Objectives: To study real-world effect of switching to Insulin Glargine 300 U/mL (Gla-300) on glucose metrics in people with type 1 diabetes. Methods: This retrospective secondary-use study compared 151 adults who switched to Gla-300 from first-generation long-acting insulins (Switchers) to 281 propensity-score …

be (code pays fourni par la source)

Sustained Impact of Intermittently Scanned Continuous Glucose Monitoring on Treatment Satisfaction and Severe Hypoglycemia in Adults with Type 1 Diabetes (FUTURE): An Analysis in People with Normal and Impaired Awareness of Hypoglycemia

Sara Charleer, Christophe E.M. De Block, Nancy Bolsens, Liesbeth Van Huffel et autres

Objective: Nationwide reimbursement of intermittently scanned continuous glucose monitoring (isCGM) was introduced in Belgium (2016). This real-world observational study investigates the impact of isCGM over 24 months on adults with type 1 diabetes with impaired or normal awareness of hypoglycemia (IAH or …

be (code pays fourni par la source)

Effect of nationwide reimbursement of real-time continuous glucose monitoring on HbA1c, hypoglycemia and quality of life in a pediatric type 1 diabetes population: The RESCUE-pediatrics study

Francesca De Ridder, Sara Charleer, Seppe Jacobs, Nancy Bolsens et autres

Objective Real-time continuous glucose monitoring (RT-CGM) can improve metabolic control and quality of life (QoL), but long-term real-world data in children with type 1 diabetes (T1D) are scarce. Over a period of 24 months, we assessed the impact of RT-CGM reimbursement on …

be (code pays fourni par la source)

Fast-acting insulin aspart improves glucose control in a real-world setting: a 1-year multicenter study in people with type 1 diabetes using continuous glucose monitoring

Lisa Billion, Sara Charleer, Laurens Verbraeken, Mira Sterckx et autres

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Lipohypertrophy monitoring study (LIMO): effect of injection site rotation and education on glycemic control

Niels Bochanen, Katelijn Decochez, Els Heleu, Joke Cuypers et autres

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Lipohypertrophy Monitoring Study (LIMO): Effect of single use of 4 mm pen needles combined with education on injection site rotation on glycaemic control: Confirmation of an unpleasant truth

Niels Bochanen, Katelijn Decochez, Els Heleu, Joke Cuypers et autres

AIMS: To investigate whether single use of 4 mm needles combined with education about injection technique and lipohypertrophy affects HbA1c, hypoglycaemia and glucose variability. METHODS: Insulin-injecting people with diabetes recruited from nine Belgian diabetes centres were prospectively followed for 6 months. They …

be (code pays fourni par la source)

Glucose control using fast‐acting insulin aspart in a real‐world setting: A 1 ‐year, two‐centre study in people with type 1 diabetes using continuous glucose monitoring

Lisa Billion, Sara Charleer, Laurens Verbraeken, Mira Sterckx et autres

AIM: To evaluate the efficacy and safety of switching from traditional mealtime insulins to fast-acting insulin aspart (Fiasp) in a "real-world" clinical practice setting in adult people with type 1 diabetes (PWD1) who were using intermittently scanned or real-time continuous glucose monitoring …

be (code pays fourni par la source)

Author response for "Glucose control using fast-acting insulin aspart in a real-world setting: A 1-year, two-centre study in people with type 1 diabetes using continuous glucose monitoring"

Lisa Billion, Sara Charleer, Laurens Verbraeken, Mira Sterckx et autres

726-P: Glucose Control Using Fast-Acting Insulin Aspart in a Real-World Setting: A One-Year Multicenter Study in People with Type 1 Diabetes Using Continuous Glucose Monitoring

Lisa Billion, Sara Charleer, Laurens Verbraeken, Mira Sterckx et autres

Objective: Data on switching from traditional mealtime insulin analogs to fast-acting insulin aspart (Fiasp) in routine clinical practice are sparse. The aim was to evaluate the efficacy and safety of this switch in a “real-world” clinical practice setting in adult people with …